Investigators advised clinicians of the potential for dystrophies that mimic age-related macular degeneration and other ...

However, the most common form of macular degeneration, dry AMD, causes permanent vision loss. If you’ve recently noticed changes in your vision or how your eyes feel, seek an appointment with an ...

It is caused by abnormal blood vessel growth (a condition referred to as 'wet' macular degeneration) or atrophy and accumulation of debris ('dry' macular degeneration), both of which damage the ...

The startup is bringing into Phase 1 testing an experimental treatment it says could be more effective than marketed ...

So about 2 years ago, the FDA approved 2 different treatments that helped slow down the growth of atrophy from dry macular degeneration. These are also medicines that we inject into the eye ...

A New Jersey-based biotech is looking to become the main character in the age-related macular degeneration field. | A New Jersey-based biotech is looking to become the main character in the ...

The Food and Drug Administration (FDA) has approved the marketing of Valeda Light Delivery System, the first therapeutic option to treat dry age-related macular degeneration in adults. Valeda uses ...

Incorporate omega-3s into your diet: Foods like fish have been shown to reduce the risk of macular degeneration. Don’t forget to add a handful of walnuts to your meals as they’re also packed with ...

Among patients diagnosed with intermediate-stage age-related macular degeneration, a fair number of eyes in a new analysis showed evidence of geographic atrophy (GA), a leading cause of blindness.

The funding will help fund phase 1 and phase 2 proof-of-concept studies for lead candidates CTX203 and CTX114.

Co-led by new investors aMoon and Luma Group, Bausch + Lomb, Jefferson Life Sciences and others also participated in the funding, which will accelerate the advancement of pipeline precision therapies ...